Jaspar Witteler1, Troels W Kjaer2, Soeren Tvilsted3, Steven E Schild4, Dirk Rades5. 1. Department of Radiation Oncology, University of Lübeck, Lübeck, Germany. 2. Neurological Department, Zealand University Hospital, Roskilde, Denmark. 3. Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark. 4. Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A. 5. Department of Radiation Oncology, University of Lübeck, Lübeck, Germany dirk.rades@uksh.de.
Abstract
BACKGROUND/AIM: Seizures represent a common manifestation of gliomas. This study evaluated the prevalence of pre-radiotherapy seizures, potential risk factors and associations with survival. PATIENTS AND METHODS: Eight factors were analyzed in 222 patients for associations with seizures including number, size and location of glioma, World Health Organization (WHO) grade, performance score, gender, age and upfront resection. These factors plus pre-radiotherapy symptoms and seizures were assessed for survival. RESULTS: Prevalence of pre-radiotherapy seizures was 29.3%. A significant correlation was found for grade II (p=0.002), trends for age ≤59 years (p=0.123) and lack of upfront resection (p=0.113). Unifocal gliomas (p<0.001), grade II (p=0.045) and upfront resection (p<0.001) showed significant associations with survival (univariate analyses). A trend was found for seizures (p=0.075) and age ≤59 years (p=0.091). In the multivariate analysis, grade II (p=0.002) and upfront resection (p=0.004) maintained significance; unifocal gliomas showed a trend (p=0.062). CONCLUSION: Pre-radiotherapy seizures appeared to be correlated with WHO grade, age and lack of upfront resection, and with better survival. Copyright
BACKGROUND/AIM: Seizures represent a common manifestation of gliomas. This study evaluated the prevalence of pre-radiotherapy seizures, potential risk factors and associations with survival. PATIENTS AND METHODS: Eight factors were analyzed in 222 patients for associations with seizures including number, size and location of glioma, World Health Organization (WHO) grade, performance score, gender, age and upfront resection. These factors plus pre-radiotherapy symptoms and seizures were assessed for survival. RESULTS: Prevalence of pre-radiotherapy seizures was 29.3%. A significant correlation was found for grade II (p=0.002), trends for age ≤59 years (p=0.123) and lack of upfront resection (p=0.113). Unifocal gliomas (p<0.001), grade II (p=0.045) and upfront resection (p<0.001) showed significant associations with survival (univariate analyses). A trend was found for seizures (p=0.075) and age ≤59 years (p=0.091). In the multivariate analysis, grade II (p=0.002) and upfront resection (p=0.004) maintained significance; unifocal gliomas showed a trend (p=0.062). CONCLUSION: Pre-radiotherapy seizures appeared to be correlated with WHO grade, age and lack of upfront resection, and with better survival. Copyright
Authors: Dirk Rades; Jaspar Witteler; Peter Trillenberg; Denise Olbrich; Steven E Schild; Søren Tvilsted; Troels W Kjaer Journal: In Vivo Date: 2022 Sep-Oct Impact factor: 2.406
Authors: Dirk Rades; Jaspar Witteler; Denise Olbrich; Peter Trillenberg; Steven E Schild; Soeren Tvilsted; Troels W Kjaer Journal: BMC Cancer Date: 2021-04-09 Impact factor: 4.430